DENVER--(BUSINESS WIRE)--Colorado BioScience Association highlights a banner year marked by acquisitions, investments, discoveries and partnerships during its 14th Annual Awards Dinner on Thursday, November 9 in downtown Denver at the Hyatt Regency. The event celebrates the companies, organizations and individuals who contribute to Colorado’s national reputation for innovation in life science.
As a highlight of the event, Colorado BioScience Association will announce the winners of the 2017 Company of the Year and Rising Star Awards. The awards honor companies for their achievements reaching significant milestones such as fundraising, commercialization and regulatory approvals.
April Giles, President and CEO of Colorado BioScience Association says:
“For the life science industry, 2017 brought significant fundraising, M&A activity and new breakthroughs to help people live healthier lives. Our Company of the Year and Rising Star nominees represent the innovation underway in our state. From cutting-edge treatments for cancer to new ways to treat rare eye diseases Colorado companies and institutions focus on advancing healthcare for people here in our state and around the world.”
Company of the Year Nominees
Array Biopharma: Focuses on the discovery, development and commercialization of targeted small molecule drugs to treat patients afflicted with cancer.
miRagen: Discovers and develops innovative microRNA-targeted therapies to address unmet medical needs and improve human health.
Sharklet Technologies: Creates and commercializes Sharklet®, the world’s first micro-texture that inhibits bacterial growth on surfaces.
Rising Star Nominees
CereScan: Combines state-of-the-art brain imaging technologies with a patient-centered model of care to provide the highest level of neurodiagnostics available.
Eximis Surgical: Works to ease patient discomfort, provide safe outcomes and deliver on the promise of minimally invasive surgery.
Ocugen: Is dedicated to developing innovative therapies and novel biologics for rare and underserved ocular disorders.
Additional honorees will include: Business Partner of the Year, Chairman’s Award, Volunteer of the Year, Educator of the Year, Institute Leadership and Legislator of the Year.
CBSA and the Boettcher Foundation will recognize the 2017 Class of Boettcher Investigators in the Webb-Waring Biomedical Research Awards program during the evening. The program awards early-career investigators at Colorado’s research institutions with $235,000 in grant funding to sustain three years of biomedical research and honors them with the title of Boettcher Investigator.
The event will be held on Thursday, November 9, 2017 at the Hyatt Regency Denver from 5:00 p.m. - 8:30 p.m. Sponsorships are $1,500 for a table of eight and $175 for an individual ticket. Learn more about the event and sponsorship opportunities.
About the Colorado BioScience Association
Colorado BioScience Association champions life science. We serve as the hub of Colorado’s thriving bioscience sector by connecting innovators to funding, infrastructure, research and talent. From promising young companies to established corporations and institutions, we provide opportunities for networking, education and professional development. We grow the bioscience workforce and lead business expansion policies to advance the industry in our state. CBSA represents more than 350 member organizations, including biotechnology, pharmaceutical, medical device, diagnostic, ag bio and mobile digital health companies, research and academic institutions and service providers. Learn more about us at http://www.cobioscience.com.